Breast Flashcards
Breast cancer metastasises to bone in one spot vs several spots in the bones
Best Management?
One spot: Radiation Therapy (relieves pain and prevents fractures)
Several Spots: Anticancer therapy (hormonal treatment [tamoxifen] or chemotherapy)
Extra:
Bone pain — NSAIDS and opioid drugs; radioactive therapy (strontium or samarium)
May give bisphosphonate to slow cancer
First line investigation for breast symptoms for
< 35y/o vs > 35 y/o
< 35 y/o: ultrasound (use MMG when US findings not consistent to clinical findings)
> 35 y/o: combination of MMG + breast US
Pregnant or lactating with breast symptoms
1st line IX?
US preferred over MMG
MMG can be used only if US inconsistent with clinical findings
Still safe to use MMG (can detect most breast CAs well during pregnancy)
Obesity premenopausal vs post menopausal risk for breast CA
Early life obesity in premenopausal — decreases risk (protective!)
Post menopausal obesity — increases risk of breast CA!
How often should MMG be done as per Cancer Council Australia?
Every 2 years for all women aged 50-74 years old
If => 40 years old and concerned (i.e. due to family history), can perform MMG
Paget’s Disease vs Eczema
Paget’s Disease (eczematous-looking, dry scabbing red rash of the nipple with ulceration of nipple and areola — always due to malignancy)
- unilateral
- older patients
- possible nipple discharge
- not pruritic/pustules
- deformity of nipple
- possible palpable lump
Eczema
- bilateral
- reproductive years/lactation
- no discharge
- pruritic + pustules
- normal nipple
- no lump
Paget’s Disease
Treatment?
Breast-conserving surgery (lumpectomy/partial mastectomy/WLE)
OR a mastectomy
Total mastectomy for advanced cancers
Arrange from good prognosis to worst prognosis:
Metastatic breast CA
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Metastatic Choriocarcinoma
Metastatic Seminoma
Good prognosis to worst prognosis:
- Metastatic seminoma of the testis (5-year survival rate of 95-100%)
- Hodgkin Lymphoma (5-year survival rate of 87%)
- Metastatic Choriocarcinoma (5-year survival rate of 80%)
- Non-Hodgkin Lymphoma (5-year survival rate of 71%)
- Metastatic breast CA (18-24 months) (5-year survival rate of 40%)
Red Flags for Breast Cancer
Management?
- Hard and irregular lump
- Skin dimpling and puckering
- Skin oedema (‘peau d’ orange’)
- Nipple discharge
- Nipple distortion
- Nipple eczema (Paget’s disease)
MMG+US/FNAC/Excision Biopsy(!!) even if cytology is normal
What to consider for patients with high-risk family history of breast and ovarian cancer?
- Refer to cancer specialist or family cancer clinic for risk assessment, 2. genetic testing (BRCA gene screening) and management plan
- Surveillance: regular clinical breast examination + annual breast imaging with MMG/MRI/US
After doing US (< 40 y/o) or MMG (> 40y/o), refer to breast cancer screening clinic or surgeon?
Refer to breast surgeon for further evaluation once US/MMG report is received
Vitamin A deficiency leads to what breast diseases?
Periductal Mastitis
AKA subareolar abscess
- affects young women / men,
- vitamin A (retinoids) deficiency and smoking — potential causes
[DIFFERENT FROM ductal ectasia (younger women, dilated ducts, toothpaste-like discharge)]
Aromatase Inhibitors:
- Arimidex (anatrozole)
- Femara (letrozole)
- Aromasin (exemestane)
Used to treat breast CA and ovarian CA in post menopausal women.
- blocks aromatase (enzyme that converts androgen to estrogen)
Side effects?
MOST COMMON side effects are symptoms of menopause:
Hot flashes
Night sweats
Vaginal dryness
Other possible side effects:
Muscle and joint pain
Speeds up bone thinning —> osteoporosis
May raise cholesterol
Compared to tamoxifen and raloxifene:
DVT (less than tamoxifen)
Stroke (less than tamoxifen)
Endometrial cancer (less than tamoxifen)
Osteoporosis (MORE THAN TAMOXIFEN)
Triple Test
- Clinical exam
- Imaging: MMG +/- breast US
- FNAC +/- Core Biopsy
Intermittent thin or milky discharge or nonlactational (usually serous) nipple discharge is…
Usually physiological
Frequently bilateral and arises from multiple ducts
Cause: stimulation of the nipple or to drugs (estrogen, tranquillisers)